Literature DB >> 20478379

Equivalent lipid oxidation profiles in advanced atherosclerotic lesions of carotid endarterectomy plaques obtained from symptomatic type 2 diabetic and nondiabetic subjects.

Krishna Kathir1, Joanne M Dennis, Kevin D Croft, Trevor A Mori, Antony K Lau, Mark R Adams, Roland Stocker.   

Abstract

Type 2 diabetes (T2D) increases the risk for cardiovascular disease and is thought to be associated with increased oxidative stress, a contributor to atherogenesis. Surprisingly, however, there is little direct evidence that T2D-associated oxidative stress results in increased lipid oxidation and/or decreased antioxidant capacity in human atherosclerotic lesions. The aim of this study was to measure vascular lipid oxidation and antioxidants in T2D. The arterial content of oxidized lipid and antioxidants in carotid endarterectomy specimens obtained from diabetic and normoglycemic patients was determined using high-performance liquid chromatography (HPLC), stable isotope dilution gas chromatography-mass spectrometry (GC/MS), and gas-liquid chromatography techniques. The concentrations of hydroxyoctadecanoic acid, F(2)-isoprostanes, and 7-ketocholesterol, as well as alpha-tocopherol, ascorbate, and urate were not different in the two patient groups, whether expressed per unit protein or as a ratio per parent compound. Unexpectedly, a significant decrease in the level of arterial lipid hydroperoxide was found in diabetic patients. Our results do not support the notion that advanced atherosclerotic lesions from T2D patients contain more oxidized lipids than corresponding lesions from nondiabetic subjects. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478379     DOI: 10.1016/j.freeradbiomed.2010.05.006

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

1.  Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.

Authors:  Eugenio Barone; Giovanna Cenini; Fabio Di Domenico; Sarah Martin; Rukhsana Sultana; Cesare Mancuso; Michael Paul Murphy; Elizabeth Head; D Allan Butterfield
Journal:  Pharmacol Res       Date:  2010-12-27       Impact factor: 7.658

2.  Unusual kinetic isotope effects of deuterium reinforced polyunsaturated fatty acids in tocopherol-mediated free radical chain oxidations.

Authors:  Connor R Lamberson; Libin Xu; Hubert Muchalski; J Rafael Montenegro-Burke; Vadim V Shmanai; Andrei V Bekish; John A McLean; Catherine F Clarke; Mikhail S Shchepinov; Ned A Porter
Journal:  J Am Chem Soc       Date:  2014-01-08       Impact factor: 15.419

3.  Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.

Authors:  D Allan Butterfield; Eugenio Barone; Cesare Mancuso
Journal:  Pharmacol Res       Date:  2011-04-22       Impact factor: 7.658

Review 4.  Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.

Authors:  Eugenio Barone; Fabio Di Domenico; D Allan Butterfield
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

5.  Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes.

Authors:  Hesham Alharby; Talaat Abdelati; Mostafa Rizk; Eman Youssef; Khaled Moghazy; Noha Gaber; Saeed Yafei
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-09-10

Review 6.  Evidence of Biomass Smoke Exposure as a Causative Factor for the Development of COPD.

Authors:  Sarah J Capistrano; David van Reyk; Hui Chen; Brian G Oliver
Journal:  Toxics       Date:  2017-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.